v3.25.2
Other Financial Assets
 12 Months Ended
Mar. 31, 2025
Subclassifications of assets, liabilities and equities [abstract]  
Other Financial Assets Other Financial Assets
JPY (millions)
As of March 31
20242025
Derivative assets (Note 27)
¥120,223 ¥84,369 
Investment in convertible notes at fair value through P&L (Note 27)
13,459 10,424 
Investment in debt instruments (Note 27)
1,113 91,348 
Investment in equity instruments at fair value through OCI (Note 27)
182,887 151,687 
Financial assets associated with contingent consideration arrangements (Note 27)
12,293 10,197 
Other25,892 23,576 
Total¥355,866 ¥371,600 
Non-current¥340,777 ¥351,124 
Current¥15,089 ¥20,476 
As of March 31, 2024 and 2025, equity instruments included JPY 93,962 million and JPY 78,073 million, respectively, of investments in public companies. These are considered Level 1 in the fair value hierarchy as defined in Note 27. The remainder of the equity instruments primarily relates to investments acquired in connection with collaborations and licensing agreements (Note 13) and are considered Level 3 investments in the fair value hierarchy.
As of March 31, 2024 and 2025, financial assets associated with contingent consideration arrangements are assets mainly recognized in relation to the divestiture of XIIDRA (Note 27) and are considered Level 3 investments in the fair value hierarchy.